Global Neurothrombectomy Devices Market (2021 to 2028) - Share, Size, Trends & Industry Analysis Report - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Neurothrombectomy Devices Market Share, Size, Trends, Industry Analysis Report, By Product; By End-Use, By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global neurothrombectomy devices market size is expected to reach USD 1,051.3 million by 2028 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global aging population, increasing prevalence of heart related diseases due to faulty and busy lifestyle, favorable government support and funding towards research and innovation, and product launches by the key market players in the neurothrombectomy devices industry. As per statistics published by the World Ageing (WA), in 2019, there are around 700 million people aged over 65, across the globe.

This large section of the population is largely contributing to the market growth for neurothrombectomy devices. This section of the population is more prone to heart-related ailments. Moreover, as per CDC, each year, 480,000 smokers die prematurely. In 2018, it was reported that in the U.S. around 34.2 million smokers reside and many of those are suffering from heart-related disorders.

Developed countries like the U.S. and Canada have witnessed a high prevalence of ischemic heart-related disorders. According to the estimates of the CDC, each year, on an average around 140,000 and 795,000 individuals in the U.S. die due to stroke. Also, product innovations to make the procedure less invasive by big players in the market also favoring the market growth for neurothrombectomy devices.

Similarly, as per the reports of the Stroke Report, in 2017, it was reported that around 400,000 people were suffering from long-term disability from heart stroke, and the number is expected to increase in the coming decade. Thus, the increasing prevalence of heart-related disorders is anticipated to be high impact rendering driver for the market for neurothrombectomy devices over the forecast period.

Neurothrombectomy devices industry participants include Medtronic, Stryker Corporation, Acandis GmbH, Stryker Corporation, Phenox GmbH, Penumbra Inc., and Vesalio are some of the key players operating in the market for neurothrombectomy devices. Companies in the market are focusing on product launches to retain their market dominance.

For instance, in September 2020, the U.S based entity of Johnson & Johnson Medical Devices Companies, CERENOVUS announced to introduce CERENOVUS Stroke Solutions. The services included in these three devices are designed to aid surgeons to effectively perform the clot removal process at the European Society of Minimally Invasive Neurological Therapy (ESMINT).

Heart attacks and strokes are the second leading cause of death across the globe, and it is being estimated that around 140,000 deaths occur in the U.S. alone every year. Around half of survivors become disabled and have an economic burden of around USD 34 billion on the healthcare facilities.

Companies Mentioned

• Medtronic
• Stryker Corporation
• Acandis GmbH
• Stryker Corporation
• Phenox GmbH
• Penumbra Inc.
• Vesalio

Key Topics Covered:

1. Introduction

1.1. Report Description

1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview

3.2. Data Sources

4. Neurothrombectomy Devices Market Insights

4.1. Neurothrombectomy Devices - Industry snapshot

4.2. Neurothrombectomy Devices Market Dynamics

4.3. Porter's Five Forces Analysis

4.4. PESTLE Analysis

4.5. Neurothrombectomy Devices Market Industry trends

5. Neurothrombectomy Devices Market Assessment by Product

5.1. Key Findings

5.2. Introduction

5.3. Clot Retrievers

5.4. Aspiration/Suction Devices

5.5. Vascular Snares

6. Global Neurothrombectomy Devices Market, by End Use

6.1. Key Findings

6.2. Introduction

6.3. Hospitals

6.4. Emergency Clinics

6.5. Ambulatory Surgical Centers

7. Neurothrombectomy Devices Market Assessment by Geography

7.1. Key findings

7.2. Introduction

7.3. Neurothrombectomy Devices Market - North America

7.4. Neurothrombectomy Devices Market - Europe

7.5. Neurothrombectomy Devices Market - Asia-Pacific

7.6. Neurothrombectomy Devices Market - Middle East & Africa

7.7. Neurothrombectomy Devices Market - Latin America

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis

8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Medtronic

9.2. Stryker Corporation

9.3. Acandis GmbH

9.4. Phenox GmbH

9.5. Penumbra Inc.

9.6. Vesalio

9.7. CERENOVUS

For more information about this report visit https://www.researchandmarkets.com/r/3pcti4

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900